The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Try the newly designed Company Pages!
Switch now

Astrazeneca PLC

  • AZN
  • NYSE
  • Consumer Products
  • Latest 74.72
  • Currency US$
  • Change 0.56
  • Percent Change 0.755 %
  • Volume 1,609,600
  • Fri Sep 19, 2014 04:04 PM EDT NYSE data delayed 15 minutes.
  • Open 74.78
  • Previous Close 74.16
  • High 75.02
  • Low 74.50
  • Bidx0 70.10
  • Askx0 77.00
  • 52-week High05/01 82.68
  • 52-week Low10/09 49.63
  • Beta 0.872
  • Market Cap 93,923.04M
  • EPS 1.60
  • P/E 46.70
  • Forward P/E 17.79
  • PEG 32.91
  • Annual Dividend 1.80
  • Yield 2.409

News

Financials & Calendars

Income Statement

  • Sales $25,742,000,000
  • Earnings $2,049,000,000
  • Return on Equity 9.16%

Cash Flow

  • Cash Flow --
  • Cash $4,188,000,000
  • Current Ratio 0.94

12 months ended Mar 31, 2014.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $59,390,000,000
  • Liabilities $37,913,000,000
  • Liabilities-to-Equity Ratio 1.77

Price Ratios

  • Price to Sales 3.65
  • Price to Book 4.37
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings Jul 31 $1.13 Oct 30 $1.04
Surprises Jul 31 15.04% n/a n/a
Dividends Aug 13 $0.90 n/a n/a
Splits n/a -- n/a n/a

12 months ended Sep 20, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.

Related Securities
Symbol Type Latest % Chg

Officers

  • Leif Johansson Chairman
  • Pascal Soriot Chief Executive Officer
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

2 KINGDOM STREET - LEGAL DEPAR
LONDON, X0
W2 6BD

investor-relations-kingdom-street@astraz
www.astrazeneca.com

Ideas & Discussion

Live Discussion of AZN on StockTwits
The Globe and Mail has
updated our Company Pages
Switch to the newly designed Company Pages format today for a more in-depth look at the companies you're following and pages that are easier to navigate. If you prefer the old layout after trying the new Company Pages, you can switch back anytime.